The identification of biomarkers of chemotherapy resistance in breast cancer using comparative proteomics
Background:Chemotherapy resistance is a major obstacle in effective neoadjuvant treatment for locally advanced breast cancer. The ability to predict tumour response would allow chemotherapy administration to be directed towards only those patients who would benefit, thus maximising treatment efficie...
Main Author: | |
---|---|
Other Authors: | |
Published: |
University of Hull
2011
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.550358 |